Mainsail Partners’ Bio-Optronics Acquired by Advarra, Inc.

We represented Mainsail Partners in the sale of Bio-Optronics, a software and services company dedicated to providing user-focused applications for healthcare organizations that impact operational performance and financial results, to Advarra, Inc., a portfolio company of Genstar Capital. Advarra, Inc. provides regulatory review solutions, research quality, compliance consulting services and clinical site technologies to life sciences companies, CROs, research sites, investigators and academia.

You Also May Be Interested In:

  • Served as fund formation counsel for the formation, capitalization, closing and operation of Brown Robin Partners’ current fund.

    We served as fund formation counsel for the formation, capitalization, closing and operation of Brown Robin Partners’ current fund.
  • Representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be acquired by funds managed by Stone Point Capital, with over $40 billion of assets under management; under the terms of the agreement, Tivity Health stockholders will receive $32.50 in cash per share, representing a total transaction value of $2.0 billion

    We are representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be...
    Client Type: Public Company
  • Representation of Groups360, a leading platform for booking group travel, in its $35,000,000 investment from  Zigg Capital, Blackstone Innovations Investments, and Fir Tree Partners to accelerate growth.

    We represented Groups360, a leading platform for booking group travel, in its $35,000,000 investment from Zigg Capital, Blackstone Innovations Investments,...